UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

tANCHOR: a novel mammalian cell surface peptide display system

BioTechniques, 2021-01, Vol.70 (1), p.21-28

2021

Volltextzugriff (PDF)

Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (1), p.181-186

2010

Volltextzugriff (PDF)

Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization

Current opinion in HIV & AIDS, 2017-05, Vol.12 (3), p.250-256

2017

Volltextzugriff (PDF)

The TZM-bl Reporter Cell Line Expresses Kynureninase That Can Neutralize 2F5-like Antibodies in the HIV-1 Neutralization Assay

International journal of molecular sciences, 2022-01, Vol.23 (2), p.641

2022

Volltextzugriff (PDF)

Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site

Journal of molecular biology, 2008-12, Vol.384 (2), p.377-392

2008

Volltextzugriff (PDF)

The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner

AIDS (London), 2011-03, Vol.25 (6), p.751-759

2011

Volltextzugriff (PDF)

Cloning of Single-Chain Antibody Variants by Overlap-Extension PCR for Evaluation of Antibody Expression in Transient Gene Expression

Methods in molecular biology (Clifton, N.J.), 2017-01, Vol.1603, p.57

2017

Volltextzugriff (PDF)

The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against HIV MPER

Advances in protein chemistry and structural biology, 2015, Vol.99, p.15-54

2015

Volltextzugriff (PDF)

N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies

Virologica Sinica, 2015-12, Vol.30 (6), p.449-456

2015

Volltextzugriff (PDF)

Development of an aqueous two-phase partitioning system for fractionating therapeutic proteins from tobacco extract

Journal of Chromatography A, 2006-09, Vol.1128 (1), p.114-124

2006

Volltextzugriff (PDF)

Structural Analysis of the Epitope of the Anti-HIV Antibody 2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion

Journal of molecular biology, 2003-07, Vol.330 (5), p.1101-1115

2003

Volltextzugriff (PDF)

In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes

Journal of molecular biology, 2009-01, Vol.385 (2), p.675-691

2009

Volltextzugriff (PDF)

Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration

Biochemical and biophysical research communications, 2006-09, Vol.348 (3), p.1107-1115

2006

Volltextzugriff (PDF)

Characteristics of Artificial Immunogens Containing Peptide Mimotopes of HIV-1 Epitopes Recognized by Monoclonal Antibodies 2F5 and 2G12

Bulletin of experimental biology and medicine, 2019-06, Vol.167 (2), p.259-262

2019

Volltextzugriff (PDF)

Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes

AIDS (London), 2011-02, Vol.25 (4), p.419-428

2011

Volltextzugriff (PDF)

Antigenic Characteristics of Rhinovirus Chimeras Designed in silico for En5hanced Presentation of HIV-1 gp41 Epitopes

Journal of molecular biology, 2010-04, Vol.397 (3), p.752-766

2010

Volltextzugriff (PDF)

Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules

Current topics in medicinal chemistry, 2011-12, Vol.11 (24), p.2997-3021

2011

Volltextzugriff (PDF)

Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1

The FASEB journal, 2008-12, Vol.22 (12), p.4338-4351

2008

Volltextzugriff (PDF)

Artificial polyepitope HIV-1 immunogen containing mimotope of 2F5 epitope

Protein and peptide letters, 2016-01, Vol.23 (2), p.159-168

2016

Volltextzugriff (PDF)

HIV-1 gp41 as a target for viral entry inhibition

Current pharmaceutical design, 2004-01, Vol.10 (15), p.1805-1825

2004

Volltextzugriff (PDF)

Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state

Vaccine, 2007-06, Vol.25 (27), p.5102-5114

2007

Volltextzugriff (PDF)

Characterization of a trimeric MPER containing HIV-1 gp41 antigen

Virology (New York, N.Y.), 2009-08, Vol.390 (2), p.221-227

2009

Volltextzugriff (PDF)

Confocal microscopy of giant vesicles supports the absence of HIV-1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids

FEBS letters, 2010-04, Vol.584 (8), p.1591-1596

2010

Volltextzugriff (PDF)

Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope

AIDS (London), 2009-05, Vol.23 (8), p.887-895

2009

Volltextzugriff (PDF)

Constrained peptide models from phage display libraries highlighting the cognate epitope-specific potential of the anti-HIV-1 mAb 2F5

Immunology letters, 2011-04, Vol.136 (1), p.80-89

2011

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Humans
(28)
Hiv-1 - Immunology
(23)
Human Immunodeficiency Virus 1
(23)
Hiv-1
(20)
2f5
(19)
Animals
(19)
Biochemistry & Molecular Biology
(19)
Molecular Sequence Data
(16)
Amino Acid Sequence
(15)
Hiv Envelope Protein Gp41 - Immunology
(15)
Gp41
(13)
Epitopes - Immunology
(12)
Antibodies, Monoclonal - Immunology
(11)
Biological And Medical Sciences
(11)
Aids Vaccines - Immunology
(10)
Hiv Envelope Protein Gp41 - Chemistry
(10)
Epitopes - Chemistry
(9)
Hiv
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

tANCHOR: a novel mammalian cell surface peptide display system

Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance

Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization

The TZM-bl Reporter Cell Line Expresses Kynureninase That Can Neutralize 2F5-like Antibodies in the HIV-1 Neutralization Assay

Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site

The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner

Cloning of Single-Chain Antibody Variants by Overlap-Extension PCR for Evaluation of Antibody Expression in Transient Gene Expression

The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against HIV MPER

N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies

Development of an aqueous two-phase partitioning system for fractionating therapeutic proteins from tobacco extract

Structural Analysis of the Epitope of the Anti-HIV Antibody 2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion

In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes

Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration

Characteristics of Artificial Immunogens Containing Peptide Mimotopes of HIV-1 Epitopes Recognized by Monoclonal Antibodies 2F5 and 2G12

Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes

Antigenic Characteristics of Rhinovirus Chimeras Designed in silico for En5hanced Presentation of HIV-1 gp41 Epitopes

Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules

Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1

Artificial polyepitope HIV-1 immunogen containing mimotope of 2F5 epitope

HIV-1 gp41 as a target for viral entry inhibition

Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state

Characterization of a trimeric MPER containing HIV-1 gp41 antigen

Confocal microscopy of giant vesicles supports the absence of HIV-1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids

Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope

Constrained peptide models from phage display libraries highlighting the cognate epitope-specific potential of the anti-HIV-1 mAb 2F5

Suchergebnisse filtern